Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: CEO Response to Drug Safety Crisis Day 1 Hours 1-3: Immediate Assessment & Response Team Assembly I'll immediately convene an emergency meeting with our internal research team, Chief Medical Officer, Chief Scientific Officer, and head of Pharmacovigilance to fully understand the liver failure…Read the full answer
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer